Cargando…
The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. Complete resection is the only potentially curative treatment, although recurrence is common, occurring in approximately 40–50% of patients. The introduction of effective molecularly targ...
Autores principales: | Keung, Emily Z., Raut, Chandrajit P., Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471171/ https://www.ncbi.nlm.nih.gov/pubmed/32734368 http://dx.doi.org/10.1245/s10434-020-08869-w |
Ejemplares similares
-
Defining Tumor Rupture in Gastrointestinal Stromal Tumor
por: Nishida, Toshirou, et al.
Publicado: (2019) -
Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor
por: Venkataraman, Vinayak, et al.
Publicado: (2023) -
Role of Resection Following Focal Progression with Standard Doses of Imatinib in Patients with Advanced Gastrointestinal Stromal Tumors: Results of Propensity Score Analyses
por: Cho, Hyungwoo, et al.
Publicado: (2019) -
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
por: Hølmebakk, Toto, et al.
Publicado: (2021) -
Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study
por: Zalcberg, John R., et al.
Publicado: (2021)